News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–50
Matches
50
Sources here
8
Companies here
1
Search results Stored financial headlines

Active search

50 matching headlines

Ticker or company: AQSTMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Market update Main company 🇺🇸 United States

Aquestive Therapeutics Inc (AQST) Institutional Confidence

Aquestive Therapeutics Inc (AQST) has an institutional shareholding score of 5.00, placing it 72nd within the Pharmaceuticals industry. Institutional investors collectively hold 60.30% of the shares, marking a 16.75% increase quarter-over-quarter. Bill Nygren | OAKMX is the largest institutional shareholder, holding 912.50K shares.

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Capital return Main company 🇺🇸 United States

Aquestive Therapeutics Inc (AQST) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Aquestive Therapeutics Inc (AQST) focusing on its dividend and stock split history. It notes that the company has not distributed any dividends in the past five years. The page also presents current stock performance data, including market cap …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Aquestive Therapeutics Inc (AQST) Income Statement

This article provides a detailed quarterly and annual income statement for Aquestive Therapeutics Inc (AQST), allowing investors to analyze the company's financial performance and operational efficiency. It presents data spanning several fiscal years, covering metrics such as total revenue, operating expenses, net income, and …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Market update Main company 🇺🇸 United States

ETFs Investing in Aquestive Therapeutics, Inc. Stocks

This article lists various ETFs that include Aquestive Therapeutics, Inc. (AQST) stocks in their holdings. It provides detailed financial data for each ETF, such as market value, weight of AQST in the fund, issuer, management style, expense ratio, AUM, price, change percentage, relative volume, …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
ACCESS Newswire Regulatory and legal Main company 🇺🇸 United States

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aquestive Therapeutics, Inc. (AQST) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Aquestive Therapeutics, Inc. (NASDAQ:AQST) regarding potential corporate wrongdoing by its officers and/or directors. The firm is encouraging shareholders who purchased Aquestive securities prior to June 16, 2025, and continue to hold them, to contact …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

Aquestive Therapeutics president and CEO Daniel Barber sells $100,191 in stock

Aquestive Therapeutics President and CEO Daniel Barber sold a total of $100,191 worth of company stock through two transactions on July 15 and July 16, 2026. These sales reduced his direct ownership to 610,574 shares. The sales occurred while the stock was trading at …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Enterprise value to EBITDA forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST

This page provides information on the enterprise value to EBITDA forward for Aquestive Therapeutics, Inc. (NASDAQ:AQST). It is part of a larger financial data and market analysis platform, offering various tools and community features for investors. The content specifically highlights the financial metric for …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Aquestive Therapeutics (AQST) CEO Barber sells 25,000 shares between $4.00 and $4.04

Aquestive Therapeutics (AQST) CEO Daniel Barber sold a total of 25,000 common shares on July 15-16, 2026, at prices ranging from $4.00 to $4.04 per share. These transactions were executed under a Rule 10b5-1 trading plan. Following the sales, Barber directly holds 610,574 shares …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GuruFocus Market update Main company 🇺🇸 United States

Insider Sell: Aquestive Therapeutics Inc (AQST) President and CE

Aquestive Therapeutics Inc (AQST) President and CEO Daniel Barber sold 25,000 shares of the company on July 16, 2026, reducing his total holdings to 610,574 shares. This transaction follows a pattern of 19 insider sells and no buys over the past year. With the …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Canada Regulatory and legal Main company 🇺🇸 United States

Form 4 Aquestive Therapeutics Inc For: 17 July By Investing.com

This article from Investing.com is a regulatory filing update, specifically a Form 4 for Aquestive Therapeutics Inc., dated July 17. It simply announces the availability of this standard insider transaction report for the public record.

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
ACCESS Newswire Regulatory and legal Main company 🇺🇸 United States

Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Aquestive Therapeutics, Inc. (NASDAQ:AQST) for alleged corporate wrongdoing. The law firm encourages investors who purchased Aquestive securities before June 16, 2025, and still hold them, to contact them to assist with the investigation. The …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TipRanks Earnings Main company 🇺🇸 United States

Aquestive Therapeutics, Inc. (AQST) Q3 2025 Earnings Report - Results, Call & Slides

Aquestive Therapeutics, Inc. (AQST) reported its Q3 2025 earnings, missing both EPS and revenue expectations. The company posted an actual EPS of -$0.14 against a consensus of -$0.13, and actual revenue of $12.81M compared to an expected $12.97M. The report includes details on past …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Enterprise value to EBIT forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST

This article provides financial information for Aquestive Therapeutics, Inc. (NASDAQ:AQST), specifically focusing on its enterprise value to EBIT forward. It indicates that the company's financial data and SEC filings are available through TradingView, supported by various financial data providers.

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Canada Market update Main company 🇺🇸 United States

Form 144 Aquestive Therapeutics For: 15 July By Investing.com

This article from Investing.com announces a Form 144 filing for Aquestive Therapeutics on July 15. Form 144 is a notice of the intent to sell restricted securities, indicating that insiders or affiliates of Aquestive Therapeutics plan to sell shares. The brief piece provides limited …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context